Literature DB >> 7510890

Biochemical studies on capped RNA primers identify a class of oligonucleotide inhibitors of the influenza virus RNA polymerase.

T D Chung1, C Cianci, M Hagen, B Terry, J T Matthews, M Krystal, R J Colonno.   

Abstract

A synthetic 67-nt RNA substrate, containing a 32P-labeled cap-1 structure (m7G32pppGm) was specifically cleaved by the influenza virus RNA polymerase (EC 2.7.7.48) to yield a single capped 11-nt fragment capable of directly priming transcription. An analysis of systematic truncations of this RNA substrate demonstrated that an additional nucleotide beyond this cleavage site was required for cleavage. The minimal RNA chain length required for priming activity was found to be 9 nt, while in contrast an RNA chain length of at least 4 nt was required for efficient binding to the viral polymerase. On the basis of these chain length requirements we show that a pool of capped oligonucleotides too short to prime transcription, but long enough to bind with high affinity to the viral polymerase, are potent inhibitors of cap-dependent transcription in vitro.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7510890      PMCID: PMC43373          DOI: 10.1073/pnas.91.6.2372

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Nucleotides 9 to 11 of the influenza A virion RNA promoter are crucial for activity in vitro.

Authors:  B L Seong; G G Brownlee
Journal:  J Gen Virol       Date:  1992-12       Impact factor: 3.891

2.  Nucleotide sequences at the 5'termini of rabbit alpha and beta globin mRNA.

Authors:  R E Lockhard; U L Rajbhandary
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

3.  RNA synthesis by ribonucleoprotein-polymerase complexes isolated from influenza virus.

Authors:  O M Rochovansky
Journal:  Virology       Date:  1976-09       Impact factor: 3.616

4.  Globin mRNAs are primers for the transcription of influenza viral RNA in vitro.

Authors:  M Bouloy; S J Plotch; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

5.  Transfer of 5'-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro.

Authors:  S J Plotch; M Bouloy; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

6.  Are the 5' ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs?

Authors:  R M Krug; B A Broni; M Bouloy
Journal:  Cell       Date:  1979-10       Impact factor: 41.582

7.  5' and 3' terminal nucleotide sequences of the RNA genome segments of influenza virus.

Authors:  J S Robertson
Journal:  Nucleic Acids Res       Date:  1979-08-24       Impact factor: 16.971

8.  Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.

Authors:  S A Martin; E Paoletti; B Moss
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

9.  mRNA(nucleoside-2'-)-methyltransferase from vaccinia virus. Characteristics and substrate specificity.

Authors:  E Barbosa; B Moss
Journal:  J Biol Chem       Date:  1978-11-10       Impact factor: 5.157

10.  mRNA(nucleoside-2'-)-methyltransferase from vaccinia virus. Purification and physical properties.

Authors:  E Barbosa; B Moss
Journal:  J Biol Chem       Date:  1978-11-10       Impact factor: 5.157

View more
  18 in total

1.  Activation of influenza virus RNA polymerase by the 5' and 3' terminal duplex of genomic RNA.

Authors:  M-T Michael Lee; Klaus Klumpp; Paul Digard; Laurence Tiley
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

2.  In vivo analysis of the TSWV cap-snatching mechanism: single base complementarity and primer length requirements.

Authors:  D Duijsings; R Kormelink; R Goldbach
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  A novel 3'-end repair mechanism in an RNA virus.

Authors:  P D Nagy; C D Carpenter; A E Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  Differential activation of the influenza virus polymerase via template RNA binding.

Authors:  C Cianci; L Tiley; M Krystal
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

5.  Inhibition of influenza virus transcription by 2'-deoxy-2'-fluoroguanosine.

Authors:  M Tisdale; M Ellis; K Klumpp; S Court; M Ford
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

6.  An endonuclease switching mechanism in the virion RNA and cRNA promoters of Thogoto orthomyxovirus.

Authors:  M B Leahy; J T Dessens; D C Pritlove; P A Nuttall
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  Solid phase synthesis of 5'-diphosphorylated oligoribonucleotides and their conversion to capped m7Gppp-oligoribonucleotides for use as primers for influenza A virus RNA polymerase in vitro.

Authors:  G G Brownlee; E Fodor; D C Pritlove; K G Gould; J J Dalluge
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

8.  Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.

Authors:  J Tomassini; H Selnick; M E Davies; M E Armstrong; J Baldwin; M Bourgeois; J Hastings; D Hazuda; J Lewis; W McClements
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

9.  Characterization of the RNA-fork model of virion RNA in the initiation of transcription in influenza A virus.

Authors:  E Fodor; D C Pritlove; G G Brownlee
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

10.  Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase.

Authors:  Hidehiro Sangawa; Takashi Komeno; Hiroshi Nishikawa; Atsushi Yoshida; Kazumi Takahashi; Nobuhiko Nomura; Yousuke Furuta
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.